You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Switzerland

Jun 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

OTC products are still popular

Consumer health in Switzerland continued to grow in value terms during 2011. The demanding lifestyles of the Swiss population leave little time for people to recuperate from their stressful working conditions or to visit a physician, and this situation increased demand for OTC products in 2011, in particular for the treatment of minor illnesses. In addition, health insurance contributions as well as co-payments for prescription drugs have recently increased significantly, a situation which is forcing consumers to use OTC drugs more often. Thus, the majority of categories in consumer health registered positive value growth in 2011. However, some categories suffered due to the consumer perception that their long term usage may be damaging, for example weight management products, analgesics and some paediatric health products.

Other industries encroaching on the territory of consumer health

The saturation which is being seen in various fmcg industries in Switzerland is forcing companies to target areas which have hitherto been the territory of consumer health. Thus, many leading players in Switzerland’s packaged food industry have recently launched a large number of fortified and functional products which are sold through grocery retail outlets. A high proportion of food and beverages specifically targeted at children and the ageing are currently fortified. Probiotic and functional food products which promise to tackle digestive problems, reduce cholesterol and enhance physical energy and beauty are currently sold as packaged food through grocery retail outlets. Both packaged food manufacturers and grocery retailers have expanded their fat free and low fat food ranges as part of the trend towards catering to consumers interested in maintaining a healthy diet. The Swiss beauty and personal care industry has launched a large number of skin care products which carry anti-ageing ingredients such as Co-Enzyme Q10 as well as products which treat the symptoms of skin conditions and hair loss which were previously treated through consumer health medication. Mouth care is a lucrative beauty and personal care category in Switzerland as Swiss consumers pay significant attention to their day-to-day oral hygiene routines and many companies have launched products carrying medicinal properties which are similar to adult mouth care products. These products continue to pose a stiff challenge to consumer health in Switzerland as they effectively suppress demand for products in certain consumer health categories.

Premium brands win the day

The Swiss generally value tradition and therefore the trust and loyalty placed in the premium consumer health brands of the leading multinational players and larger domestic companies remains strong. Particularly when it comes to medication and OTC products, Swiss consumers place their trust in leading companies with strong brands. As a result, the twenty top positions in consumer health in Switzerland in 2011 were held by leading multinational companies and large domestic companies with strong brands. By way of comparison, the private label consumer health products of Switzerland’s leading retailers held only marginal value shares in 2011.

Chemists/pharmacies still have the highest market share

Chemists/pharmacies was the leading distribution channel for consumer health in Switzerland during 2011, followed by parapharmacies/drugstores. Switzerland’s stringent healthcare regulations allow some medications such as analgesics to be sold only through chemists/pharmacies, while some other products which fall within the parameters of the list D can also be sold through parapharmacies/drugstores. The traditional character of the Swiss people also favours chemists/pharmacies due to the sound advice and high levels of service they receive in these outlets. Internet retailing is growing as a channel for the distribution of consumer health products, although it is technically forbidden to sell consumer health products over the internet in Switzerland. Nevertheless, consumer health products which are either unavailable in the country or difficult to obtain are ordered through overseas online shops. Even so, internet retailing currently has accounts for only a marginal proportion of consumer health distribution in Switzerland.

Consumer health category expected to grow during the forecast period

Consumer health category is expected to record positive constant value growth over the forecast period although in some categories growth will be lower than what was recorded during the review period due to saturation and low consumer demand. Swiss consumers are expected to reduce their collective intake of specific products such as analgesics and weight management products as the use of some of these is considered to be harmful over the longer term. But on the whole, the majority of consumer health categories in Switzerland will continue to register favourable growth during the forecast period due to the convenience that OTC products offer Switzerland’s time-poor consumers.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Switzerland for free:

The Consumer Health in Switzerland market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Switzerland?
  • What are the major brands in Switzerland?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Switzerland - Industry Overview

EXECUTIVE SUMMARY

OTC products are still popular

Other industries encroaching on the territory of consumer health

Premium brands win the day

Chemists/pharmacies still have the highest market share

Consumer health category expected to grow during the forecast period

KEY TRENDS AND DEVELOPMENTS

A strong economy supports consumer demand for premium brands

High health care costs encourage self-medication

Vitamins and dietary supplements benefit from the ageing population

The popularity of the internet continues to grow in Switzerland

Lifestyle changes influence consumption habits

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC - Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Switzerland - Company Profiles

Biomed AG in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

COMPETITIVE POSITIONING

  • Summary 4 Biomed AG: Competitive Position 2011

G Streuli & Co AG in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 6 G Streuli & Co AG: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 7 G Streuli & Co AG: Competitive Position 2011

Melisana AG in Consumer Health (Switzerland)

Strategic Direction

Key Facts

Company Background

Competitive Positioning

  • Summary 9 Melisana AG: Competitive Position 2011

Ricola AG in Consumer Health (Switzerland)

Strategic Direction

Key Facts

Company Background

Competitive Positioning

  • Summary 12 Ricola AG: Competitive Position 2011

ViforPharma Ltd in Consumer Health (Switzerland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 ViforPharma Ltd: Competitive Position 2011

Adult Mouth Care in Switzerland - Category Analysis

HEADLINES

TRENDS

  • The Swiss population is now paying greater attention than ever before to the maintenance of their daily oral hygiene routines as this is a socially accepted norm in the country. In addition, the message that it is vitally important to maintain comprehensive oral hygiene routines forms part of the education which all Swiss children receive in school and is also a common theme in the Swiss media. The high cost of dental treatment is another incentive for Swiss people to maintain good mouth hygiene. This situation means that Swiss people tend not to suffer from conditions such as gingivitis which require treatment with OTC adult mouth care products, resulting in lower demand for adult mouth care products throughout the review period as well as in 2011.

COMPETITIVE LANDSCAPE

  • Gaba International remained the leading company in adult mouth care in Switzerland in 2011 with a value share of 26% thanks to its Elmex and Meridol brands, which combined generated value sales of CHF6 million for the company in 2011. Between them, these brands offer a complete range of adult mouth care including toothpaste, toothbrushes and mouthwash. Gaba has positioned these products to target both adult mouth care as well as oral hygiene within beauty and personal care, thereby broadening the brands’ sales potential.

PROSPECTS

  • The competition posed to adult mouth care in Switzerland by the high growth which is being recorded in oral hygiene due to the rise of oral hygiene products with medicinal value is expected to erode the growth potential of adult mouth care during the forecast period. As a result, adult mouth care is expected to decline in constant value by 2% over the course of the entire forecast period.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Demand for analgesics in Switzerland continued to rise during 2011 as a result of busier lifestyles and rising stress levels, a situation which is leading to higher numbers of Swiss people suffering from stress-related ailments. There has recently been an upsurge in stress-related ailments as the increasingly hectic schedules of Swiss people leave them with little time to recuperate from the hustle and bustle of their daily lives. Many Swiss people do not think that it is necessary to visit a doctor when suffering from the ill-effects of stress, mainly due to the lack of time they have to arrange a doctor’s appointment and actually visit the doctor, and this motivates them to continue purchasing OTC analgesics as a quick and easy solution to their problems.

SWITCHES

COMPETITIVE LANDSCAPE

  • Analgesics in Switzerland features a balance of both international and domestic manufacturers and considering that Switzerland is home to many of the giant global pharmaceutical companies such as Novartis, it is little wonder that domestic players account for a significant value share in analgesics.

PROSPECTS

  • The busy lifestyles which the majority of Swiss people now lead will continue to intensify over the next five years and this is set to result in higher incidence of stress related illnesses in Switzerland. Many Swiss people now have little or no time to recuperate from the pressure of their hectic schedules and this also means that few of them have time to visit a doctor and this will lead to higher demand for OTC analgesics during the forecast period. Thus, analgesics is expected to increase in constant value by 15% over the forecast period.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Switzerland - Category Analysis

HEADLINES

TRENDS

  • A large number of Swiss people continue to suffer from sleep disorders, while rising stress levels due to work and finance-related worries and increasingly busy lifestyles are also making it difficult for increasing numbers of Swiss people to get a good night’s sleep. However, many Swiss people remain cautious not to use sleeping and calming medication as the long-term usage of many of the products categorised under calming and sleeping may result in addiction or dependency. Many Swiss people therefore opt for herbal relaxants and natural sleeping aids, which are generally perceived to be milder and without fewer side-effects. Calming aids are positioned as products which engender a sense of peace and serenity and these products are generally marketed towards consumers who wish to sleep well without taking heavy medication.

COMPETITIVE LANDSCAPE

  • Calming and sleeping in Switzerland was led by Bioforce AG in 2011 with a value share of 19% achieved through its Avenaforce brand. Avenaforce is a natural remedy and is popular among Swiss consumers, mainly Swiss women, as it is considered a mild product with few side-effects.

PROSPECTS

  • Calming and sleeping in Switzerland is expected to decline in constant value by 1% over the course of the entire forecast period. The cautious attitude of the Swiss towards calming and sleeping products will remain in force throughout the forecast period.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Switzerland - Category Analysis

HEADLINES

TRENDS

  • A large number of Swiss consumers moved away from chemical cough, cold and allergy (hay fever) remedies, opting instead for herbal/traditional cough, cold and allergy (hay fever) remedies to treat the common cold and allergies in 2011 as herbal/traditional products are considered to be milder and benefit from having few side-effects. In addition, when Swiss people experience severe colds and allergies they prefer to visit their doctors in order to receive the most effective medication rather than resorting to self-medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis led cough, cold and allergy (hay fever) remedies in Switzerland in 2011 with a value share of 17%. Its main brands in the category include the following: Neo Citran, which held a 5% value share in 2011; Otrivin with a 3% value share; and Mebucaine and Vibrocil, each of which accounted for 2% of total value sales in cough, cold and allergy (hay fever) remedies in Switzerland during 2011. The company offers a large number of products in the category under several brands, and this is what has enabled it to maintain its leadership.

PROSPECTS

  • The shift away from OTC cough, cold and allergy (hay fever) remedies towards more natural herbal/traditional cough, cold and allergy (hay fever) remedies is expected to continue during the forecast period, limiting growth to lower than the growth recorded during the review period. Cough, cold and allergy (hay fever) remedies is set to increase in constant value at a CAGR of 1% over the forecast period.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Switzerland - Category Analysis

HEADLINES

TRENDS

  • The fairly new category of proton pump inhibitors increased in value by 4% in 2011 following the introduction of new brands including Omed Antacid by Sandoz Pharma AG, Omep Akut by Hexal AG and Antra by Bayer Vital GmbH. These brands joined existing brand Pantozol Control by Nycomed Pharma AG.

SWITCHES

COMPETITIVE LANDSCAPE

  • A significant proportion of digestive remedies value sales are accounted for by the leading multinational pharmaceutical companies. These large companies invest large sums on advertising and promotion for their digestive remedies. Thus, many of their digestive remedies brands have become household names and are already established items in household medicine cabinets across Switzerland. However, the participation of a significant number of leading companies and their strong brands has contributed to saturation from which digestive remedies is currently suffering. Brand loyalty is very strong in digestive remedies in Switzerland and as a result of this economy brands and private label digestive remedies remain unpopular in the country.

PROSPECTS

  • Digestive remedies in Switzerland is expected to decline in constant value at a CAGR of -1% over the forecast period as a result of the category’s maturity and the resulting low consumer demand. In addition, the health consciousness of the Swiss population is also on the rise and increasing numbers of Swiss people are attempting to improve their eating habits. This health and wellness trend is set to have a positive impact on the lifestyles of Swiss consumers during the forecast period, limiting demand for digestive remedies.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Daily ear care in Switzerland is generally restricted to cleaning one’s ears with cotton buds and the Swiss are accustomed to going to the doctor to have their inner ears cleared of wax or for the treatment of other ear ailments rather than using OTC ear care products. This lack of confidence in the self-medication of ear problems continued to have a negative effect on ear care in Switzerland during 2011.

COMPETITIVE LANDSCAPE

  • Zambon Schwarz led ear care in Switzerland in 2011 with a 27% value share thanks to its leading brand Otipax, which enjoys very wide distribution through chemists/pharmacies across Switzerland. Optipax is primarily a painkiller which can be used for the pain resulting from injury or earache stemming from the common cold.

PROSPECTS

  • Ear care in Switzerland is expected to decline by 14% in constant value over the course of the forecast period at a CAGR of -3%. Ear care is likely to suffer from the widespread attitude among Swiss consumers that the ailments which ear care products aim to treat are best dealt with by seeking the attention of a physician.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Switzerland - Category Analysis

HEADLINES

TRENDS

  • The increasingly liberal lifestyles of the youth in Switzerland helped boost value growth in emergency contraception during 2011. Emergency contraception is mainly used by young women, many of whom do not have access to information about preventative birth control methods.

COMPETITIVE LANDSCAPE

  • The only emergency contraception product which is currently available in Switzerland is NorLevo by Sandoz Pharmaceuticals AG. Thus, Sandoz accounted for 100% of total retail value sales in emergency contraception in Switzerland during 2011.

PROSPECTS

  • Emergency contraception in Switzerland is expected to increase in constant value by 9% over the course of the entire forecast period. Value growth in emergency contraception is expected to be lower during the forecast period than during the review period as the information about emergency contraception which is available through the Swiss medical establishment encourages the use of preventative birth control techniques and actively discourages the frequent use of emergency contraception.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2006-2011
  • Table 54 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 55 Emergency Contraception Company Shares by Value 2007-2011
  • Table 56 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 57 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Long hours spent staring at computer screens in stuffy offices, the drying of the air in living and working spaces caused by the use of air conditioning and heating and rising levels of environmental pollution, particularly in Swiss cities, all led to an increase being recorded in the incidence of red and dry eyes in Switzerland during 2011. In addition, the number of allergy sufferers throughout Switzerland increased during the review period. This is leading increasing numbers of Swiss consumers to turn to the daily use of eye care products in order to address the discomfort of dry and tired eyes.

COMPETITIVE LANDSCAPE

  • The competitive landscape in eye care in Switzerland was dominated during 2011 by a small number of leading multinational and domestic companies with strong brands. This relatively high level of consolidation in the category can be attributed to the high level of trust and confidence in eye care products which Swiss consumers demand, a level which only leading companies with significant advertising budgets are able to provide through brand building.

PROSPECTS

  • The busy lifestyles of Swiss people and the rising levels of environmental pollution in Swiss cities are set to continue contributing to increasing incidence of dry and red eyes in Switzerland as well as creating conditions which exacerbate allergies which require treatment with eye care products, requiring the daily use of eye care products. Based on this situation, eye care in Switzerland is expected to increase in constant value by 5% over the course of the entire forecast period.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2006-2011
  • Table 60 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 61 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 62 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 63 Eye Care Company Shares by Value 2007-2011
  • Table 64 Eye Care Brand Shares by Value 2008-2011
  • Table 65 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 66 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products continued to enjoy high popularity in Switzerland during 2011 due to the widespread consumer perception that herbal/traditional products are safe and mild consumer health products with little or no side-effects, especially in comparison with chemical-based medicines and drugs. Switzerland has a long cultural tradition of the use of medicinal herbs and the preparation of traditional herbal remedies is still prevalent in rural communities across Switzerland, a factor which increases the acceptance of herbal/traditional products among the Swiss population. Thus, herbal/traditional products in Switzerland increased in value by 2% during 2011, and this growth was commensurate with the 2% current value CAGR recorded over the entire review period.

COMPETITIVE LANDSCAPE

  • Ricola AG ranked first in herbal/traditional products in 2011 with a value share of 10% due to the strength of its Ricola brand. Ricola led in herbal/traditional cough, cold and allergy (hay fever) remedies in 2011 with a value share of 23%. Ricola AG is a domestic company which enjoys high consumer awareness and brand equity and its value share continues to increase as a result of innovative product launches.

PROSPECTS

  • Herbal/traditional products is expected to increase in constant value by 7% over the course of the entire forecast period due to the widespread consumer perception that herbal/traditional products are safer and milder than chemical-based medication. In addition, the health and wellness trend which continues to build in Switzerland is also set to boost consumer demand for herbal/traditional products during the forecast period.

CATEGORY DATA

  • Table 67 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 68 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 69 Herbal/Traditional Products Company Shares 2007-2011
  • Table 70 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 71 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 72 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Saturation in beauty and personal care in Switzerland is forcing many cosmetics companies to expand into niche areas with so-called ‘cosmeceutical’ products, cosmetics which take on a pharmaceutical character. Examples of these are shampoos which contain caffeine to prevent hair loss, soaps and sprays with antibacterial characteristics and skin care creams and lotions for the treatment of itchy and flaky skin and acne. These products continued to encroach onto the territory of medicated skin in 2011, limiting demand as Swiss consumers showed an enthusiasm for mass market beauty and personal care products for the prevention and treatment of a variety of minor skin problems, although in the majority of cases, the sufferers of serious skin conditions still eventually turned to medicated skin care products.

COMPETITIVE LANDSCAPE

  • The leading player in medicated skin care in Switzerland in 2011 was Bayer, which held a value share of 18%. Bayer’s Bepanthen remained the leading brand in the category with a 10% value share, while its Canesten was the third leading brand with a value share of 5%. Bayer’s Dermacalm brand also held a value share of 3%. Bayer’s wide range of medicated skin care umbrella brands target a large number of skin conditions and each of them contains a wide range of specific products. This strategy has enabled Bayer to gain significant value share in medicated skin care in Switzerland and has contributed to its success.

PROSPECTS

  • The innovative ‘cosmeceutical’ products with medicinal characteristics which are being launched in beauty and personal care by the leading players in Switzerland’s cosmetic industry will continue to divert value sales from medicated skin care in Switzerland during the forecast period. However, the reluctance of Swiss doctors to prescribe medication for minor skin ailments will force many Swiss consumers to purchase OTC consumer health products, and this will mitigate the negative effects of the rising demand for so-called ‘cosmeceuticals’. As a result, medicated skin care is expected to increase in constant value by 4% over the course of the entire forecast period.

CATEGORY DATA

  • Table 73 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 74 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 75 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 76 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 77 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 79 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Over the course of the previous decade, the proportion of Switzerland’s population who smoke has declined from 25% in 2001 to 21% in 2011. The number of smokers in the country is continuously declining as the government, the medical establishment and the anti-smoking lobby have combined to encourage Swiss people to stop smoking. This is being achieved mainly by publicising the negative effects of smoking on human health over a long period of time. The smoking ban which was enforced in the majority of public places in Switzerland in 2010, including all restaurants and bars, has also had a strong effect on the prevalence of cigarette smoking as a habit among Swiss people. As a result, many Swiss people are now resorting to purchasing NRT smoking cessation aids in order to help alleviate the stress which is associated with giving up smoking.

SWITCHES

COMPETITIVE LANDSCAPE

  • Two multinational companies continue to completely dominate NRT smoking cessation aids in Switzerland. Pfizer AG, owned at GBO level by Johnson & Johnson, had a value share of 78% with its Nicorette brand, while Novartis accounted for the remaining 22% value share with its Nicotinell brand.

PROSPECTS

  • NRT smoking cessation aids in Switzerland is expected to increase in constant value by 3% over the course of the entire forecast period at a CAGR of 1%. This growth is set to be lower than the constant value growth recorded during the review period due to the maturity of category. In addition, it is assumed that the majority of Swiss smokers who would be willing to give up smoking have already done so and the remaining smokers in the country are the diehard nicotine addicts who would find it difficult or even impossible to quit the habit altogether.

CATEGORY INDICATORS

  • Table 80 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 81 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 82 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 83 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 84 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 85 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 86 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition in Switzerland remains a category of products which are consumed almost exclusively by regular gym-goers and serious athletes. During the review period, however, heightened advertising and promotions activity from the category’s leading manufactures began to target consumers who merely seek to engage in healthier lifestyle habits. For example, the high protein content of many of the products categorised under sports nutrition can also be beneficial to consumers who are vegetarians and lack protein in their diet.

COMPETITIVE LANDSCAPE

  • Sponser Sportnahrung maintained the leading position in sports nutrition in Switzerland during 2011 with a value share of 40%. Sponser Sportnahrung is a company of Swiss origin and enjoys high consumer credibility in the country. The company offers a wide range of sports nutrition products which cater to a broad consumer base and its products are now sold through sports goods stores outlets owned by Migros as well as over the internet. The company’s progressive approach to the distribution of its products has enabled it to build a diverse distribution network.

PROSPECTS

  • Sports nutrition in Switzerland is expected to increase in constant value by 7% over the course of the entire forecast period. The rising health consciousness of the Swiss population which is evident in the rising proportion of Swiss people who hold memberships for gymnasia and health clubs and the phenomenal growth in the popularity of extreme sports is set to continue supporting higher consumer demand for sports nutrition during the forecast period.

CATEGORY DATA

  • Table 88 Sales of Sports Nutrition: Value 2006-2011
  • Table 89 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 90 Sports Nutrition Company Shares 2007-2011
  • Table 91 Sports Nutrition Brand Shares 2008-2011
  • Table 92 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Switzerland - Category Analysis

HEADLINES

TRENDS

  • A significant amount of packaged food sold in Switzerland, including bread and pasta, as well as certain beverages such as fruit/vegetable juice and lemonade are now fortified with various dietary supplements. Moreover, in Switzerland a very high proportion of packaged food which specifically target children and the elderly are currently fortified. This situation has given rise to the consumer attitude that the additional purchase of vitamins and dietary supplements is unnecessary and that vitamins and dietary supplements are superfluous and non-essential products.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The competitive landscape in vitamins and dietary supplements is extremely fragmented due to the sheer diversity and high number of products which are included within the category. Bayer (Schweiz) AG ranked first in vitamins and dietary supplements during 2011 and accounted for a significant proportion of value sales with a value share of 21% due to its large number of leading brands in several different vitamins and dietary supplements categories. Bayer’s brands include Supradyn, which accounted for 6% of total vitamins and dietary supplements value sales in 2011, while its brands Biovital, Redoxon and Berocca each accounted for 4% each its Elvit brand held a 1% value share. Bayer was also the leading player in vitamins in 2011 with a 37% value share.

PROSPECTS

  • Vitamins and dietary supplement is expected to increase by 5% over the course of the entire forecast period. Growth is expected despite the ongoing rise in the supply of fortified and functional packaged food by some of the leading players in the Swiss packaged food industry is a response to rising demand and the negative publicity about the use of vitamins and dietary supplements and the resultant confusion felt by many Swiss consumers about these products caused by the conflicting information from the Swiss medical establishment and the pro-vitamin lobby will continue to compromise growth potential for vitamins and dietary supplements in Switzerland during the forecast period. The convenience of purchasing functional and fortified packaged food as opposed to wrangling with the pros and cons of vitamins and dietary supplements also poses a threat to growth in vitamins and dietary supplements in Switzerland during the forecast period.

CATEGORY DATA

  • Table 94 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 96 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 97 Dietary Supplements by Positioning 2006-2011
  • Table 98 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 99 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 100 Vitamins Brand Shares by Value 2008-2011
  • Table 101 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 103 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Switzerland - Category Analysis

HEADLINES

TRENDS

  • The rapid proliferation of low-priced low fat and low calorie packaged food in Swiss grocery outlets eroded consumer demand for weight management in Switzerland in 2011. By contrast with very affordable low fat and low calorie packaged food, weight management products are often too expensive for the average Swiss consumer to be able to afford on a regular basis. In addition, meal replacement products in general are perceived as being unhealthy by Swiss consumers. Thus, negative publicity, high prices and the prevalent consumer opinion that weight management products are superfluous combined to have a negative effect on consumer demand for weight management products in Switzerland during 2011.

COMPETITIVE LANDSCAPE

  • Direct selling company Herbalife held the highest value share of 45% in weight management in Switzerland in 2011, well ahead of its competitors. Its Formula1 brand was the most popular brand in weight management in Switzerland during 2011 with a value share of 42%, while its Herbalife brand accounted for a further 3% of weight management value sales in 2011. However, Herbalife’s value share declined by three percentage points over the course of the review period due to the fact that increasing numbers of Swiss consumers are now purchasing weight management products from store-based retailing outlets such as chemists/pharmacies and grocery retailers as well as through internet retailing due to the convenience and lower prices which these channels offer. Moreover, Swiss people tend to trust the advice of their pharmacists, making it less likely that they will trust the advice of direct selling agents.

PROSPECTS

  • Weight management in Switzerland is set to continue facing stiff competition from low fat and low calorie packaged food. The consumer perception that weight management products are inherently unhealthy and potentially harmful over the long term is set to persist in Switzerland, and this is expected to result in low consumer demand for weight management products. Thus, weight management in Switzerland is expected to decline in constant value by 16% over the entire forecast period. Meal replacement slimming is expected to decline in constant value by 26% over the forecast period, while OTC obesity is set to decline by 53% and weight loss supplements by 3%.

CATEGORY DATA

  • Table 104 Sales of Weight Management: Value 2006-2011
  • Table 105 Sales of Weight Management: % Value Growth 2006-2011
  • Table 106 Weight Management Company Shares 2007-2011
  • Table 107 Weight Management Brand Shares 2008-2011
  • Table 108 Forecast Sales of Weight Management: Value 2011-2016
  • Table 109 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Switzerland - Category Analysis

HEADLINES

TRENDS

  • Wound care in Switzerland is a category which had already reached maturity before 2011 and the category now faces saturation. This is leading to low consumer demand, which continued to affect value growth in 2011. Although the Swiss are extremely brand loyal and generally favour products offered by leading companies, the popularity of private label wound care increased in 2011, another factor limiting value growth in the category. As such, the 1% value growth recorded in wound care in Switzerland in 2011 was lower than the 2% current value CAGR recorded over the entire review period.

COMPETITIVE LANDSCAPE

  • IVF Hartmann AG was the leading player in wound in Switzerland in 2011 with a value share of 34% thanks to its leading brand Dermaplast. Hartmann led first aid kits in 2011 with a 40% share and gauze, tape and other wound care products with a 42% value share. The company specialises in the supply of wound management products through institutional channels to healthcare institutions and these are generally highly sophisticated products. Hartmann distributes approximately 25% of its total wound care range through OTC channels.

PROSPECTS

  • Saturation is set to continue to have an influence over wound care during the forecast period and private label is set to attract a higher number of consumers, stealing value share from the leading brands. This will continue to erode the growth potential within the product category, leading to the category declining in constant value by 1% over the course of the entire forecast period.

CATEGORY DATA

  • Table 110 Sales of Wound Care by Category: Value 2006-2011
  • Table 111 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 112 Wound Care Company Shares by Value 2007-2011
  • Table 113 Wound Care Brand Shares by Value 2008-2011
  • Table 114 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 115 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Artichoke
            • Pumpkin Seed
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Silica
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!